© ISO 2016 Needle based injection systems for medical use — Requirements and test methods — Part 7 Accessibility for persons with visual impairment Systèmes d’injection à aiguille pour usage médical —[.]
Trang 1Needle-based injection systems for
Trang 2COPYRIGHT PROTECTED DOCUMENT
© ISO 2016, P blshed in Sw itz rlan
A ll rig hts r eserved Unles otherw ise spe ified, nopar of this p blc tion ma y be r epr od c d or utilz d otherw ise in an form
or b an me ns, ele tr onic or me hanic l, inclu in p oto opying , or postin on the internet or an intranet , w ithout prior
written permis ion Permis ion c n be req esed from either ISO at the ad r es below or ISO’s member bod y in the c u try of
Trang 3F reword i v
Introduction v
1 Sc ope 1
2 Nor mati ve r eferenc es 1
3 Terms an definitions 2
4 Req irements 3
4.1 R isk analysis req irement 3
4.2 General r eq ir ements 3
4.2.1 NISdesig n 3
4.2.2 Packag ing desig n 4
5 Test metho s 4
5.1 Ve ification tes ing 4
5.2 Summative ev luation (v ldation tes ing ) 5
5.2.1 General 5
5.2.2 Use p pulations 5
5.2.3 C ntex t of use 5
6 Test rep r t 5
7 Infor mation sup led b the manufacturer 6
7.1 General 6
7.1.1 Ove view 6
7.1.2 Tactie information 6
7.1.3 Auditory information 6
7.1.4 Information pr ovided in ele tronic format 6
7.2 Mar king 6
7.2.1 Mar king on the NIS 6
7.2.2 Mar king on the u it packag ing 7
7.3 Ins ructions for use 7
A nne x A (informative)Me sur ing visio and visual impair ment: F nctio al vision and visual acuity 9
A nne x B (informative)Guidanc e for develo ing instructio s for use for per o s w ith visual impairment 13
A nne x C (informative) Pr oc es for establshing a specificatio , test metho s and verification related to 5.1 15
Biblog raphy 18
Trang 4ISO (he Int ernational Org nization for Stan ardization) is a worldwidefede ation of national s an ards
b dies (ISO membe b dies) The work of pr p ring Int ernational Stan ards is normaly car ied out
through ISO t ech ical committ ees Each membe b dy int er st ed in a subje t for w hich a t ech ical
committ ee has be n es a lshed has the right t o be r pr sent ed on that committ ee Int ernational
org nizations, g ove nmental an non-g ove nmental, in laison with ISO, also take part in the work
ISO cola orat es closely with the Int ernational Ele trot ech ical C mmis ion (IEC) on al matt ers of
ele trot ech ical s an ardization
The proc d r s used t o develo this document an those int en ed for it furthe maint enanc ar
desc ibed in the ISO/IEC Dir ctives, Part 1 In p rticular the dife ent a pro al c it eria ne ded for the
dife ent ty es of ISO document should be not ed This document was draft ed in ac ordanc with the
edit orial rules of the ISO/IEC Dir ctives, Part 2 ( e www.iso.org dir ctives)
A tt ention is drawn t o the p s ibi ity that some of the element of this document ma be the subje t of
p t ent right ISO shal not be held r sp nsible for identifying any or al such p t ent right Detais of
any p t ent right identified d ring the develo ment of the document wi be in the Introd ction an / r
on the ISO ls of p t ent de larations r c ived ( e www.iso.org p t ent )
Any trade name used in this document is information given for the convenienc of use s an does not
cons itut e an en orsement
F or an ex lanation on the meaning of ISO spe ific t erms an ex r s ions r lat ed t o conformity
as es ment, as wel as information a out ISO’ s adhe enc t o the WTO principles in the Te h ical
Bar ie s t o Trade (TBT) se the fol owing URL: F or word - Sup lementary information
The committ ee r sp nsible for this document is ISO/TC 84, Devic es fr admini s tratio o medic in l
produc ts a d c athete s
ISO 1 6 8 consis s of the folowing p rt , u de the g ene al title Ne dle -b s ed injec tio sys tems fr
medic al us e — R eq ir ment a d tes t meth ds:
— Part 1: Ne dle -b s ed injec tio sys tems
— Part 2 : Ne dles
— Part 3 : Fini shed c ontaine s
— Part 4: Ne dle -b s ed injec tio sys tems c ontainin elec tro ic s
— Part 5: Automated f nc tio s
— Part 6 : On-b dy deliver y sys tems
— Part 7: Ac c es s ibi t y fr pe s ons w ith v i s ual imp irment
Trang 5Prior t o this p rt of ISO 1 6 8, the ISO 1 6 8se ies has not pro ided guidanc t o ad r s the use of NIS
b pe sons with visual imp irment The r al ty, however, is that a significant n mbe of NIS use s ha e
visual imp irment an o e at e these devic s, even though the use int erfac s r ly primari y on visual
commu ication t o pro ide the information ne ded for safe an efe tive use The r sult is that use s
with visual imp irment ha e difficulty an ma be at gr at er risk w hen using these prod ct
Given the pr v lenc of visual impairment an the fact that many NIS targ et disease s at es (e.g
dia et es) with co-morbid con itions that can imp ir vision, efort should be made t o el minat e or
minimiz , w he e p s ible, devic featur s that cons itut e o s ructions t o prod ct use for use s with
visual impairment
This part of ISO 1 6 8 defines t erms r lat ed t o visual imp irment and pro ides guidanc t o ena le
man factur rs t o pro ide information t o the use in othe sensory format (e.g tactie, a udit ory) New
an exis ing featur s that ad r s the ne dsof use s with visual imp irment wi l also benef it a bro de
p pulation
The purp se of this p rt of ISO 1 6 8 is t o as is man factur rs in develo ing NIS designs that wi l be
usa le for use s with visual imp irment but r co niz s that those designs could be mor usa le also
for use s with no visual imp irment Taking this ty e of “ unive sal design”
[2 ]
a pro ch is pr fe a le t o
the c eation of “ niche” prod ct only for use s with visual impairment, for w hich the market would be
smale and, conseq ently, the prod ct cos lkely would be highe Ap lying unive sal design principles
t o ext en ac es t o use s with visual impairment can inc ease the market siz , the eb r d cing
prod ct cos an ena lng a bro de p tient p pulation t o ac es the NIS
F or prod ct design purp ses, it should be as umed that some use s wi l ha e mode at e visual
imp irment but wi l be a le t o r ad larg e print and se high-contras prod ct featur s Othe use s,
howeve , wi not be a le t o make use of any visual featur s an wi l inst ead r q ir information t o
be pro ided through othe sensory means (e.g tacti e or au it ory) The efor , this p rt of ISO 1 6 8
inclu es the r q ir ment t o pro ide information in visual format that can be pe c ived an u de st ood
b peo le with mode at e visual imp irment and in non-visual format (e.g tactieor au it ory) that can
bepe c ived an u de st ood b peo le with no useful vision
In conju ction with othe p rt of the ISO 1 6 8 se ies, man factur rs ar ex e t ed t o folow a
risk-b sed a pro ch an emplo h man fact ors engine ring d ring the design, develo ment, an
man factur of NIS se ving this important use p pulation Exis ing prod ct an those cur ently
un e develo ment ma not fulf il some of the r q ir ment given b this p rt of ISO 1 6 8 Howeve ,
man factur rs would be wel advised t o folow it pro isions w hen impro ing exis ing prod ct or
develo ing new prod ct t o o tain a highe level of ac es ibi ty
Guidanc on transition pe iods for implementing the r q ir ment of this Int ernational Stan ard is
given in ISO/TR 1 244
Trang 7Needle-based injection systems for medical use —
Part 7:
This p rt of ISO 1 6 8 spe ifies p rticular r q ir ment t o make ne dle-b sed drug delve y sy st ems
or NIS (ne dle-b sed inje tion sy st em) ac es ible for pe sons with visual imp irment It a ples t o
devic s int en ed for p tient or car give adminis ration of medicinal prod ct t o h mans
This p rt of ISO 1 60 co e s r q ir ment t o alow for safe an cor e t han l ng of the NIS, inclu ing
la el ng, p cka ing, and ins ructions for use It also inclu es r q ir ment for training pro rams, if
a plca le
This p rt of ISO 1 6 8 co e s r q ir ment for NIS that ar claimed t o be a pro riat e for use b
pe sons with visual impairment
This p rt of ISO 1 60 does not ad r s r q ir ment for use of sharps containe s b pe sons with
visual impairment
Although spe ifical y int en ed t o a ply t o ne dle-based inje tion sy st ems within the ISO 1 60 se ies,
this p rt of ISO 1 6 8 can be a pled t o NIS out ide the ISO 1 6 8 se ies as wel , if they might be used
b pe sons with visual impairment
This part of ISO 1 60 is writt en t o ad r s the ne ds of pe sons with al levels of visual l mitations,
inclu ing low, mode at e, or seve e visual impairment ; leg l, fu ctional, or t otal bl n nes ; an colour
vision def iciencies
The efor , this p rt of ISO 1 6 8 inclu es the r q ir ment t o pro ide information in visual format
that can be pe c ived an u de st ood b peo le with mode at e visual imp irment an in non-visual
format (e.g tactie or au it ory) that can be pe c ived an u de st ood b peo le with no useful vision
F or simpl city’s sake, this rang e is desc ibed in this p rt of ISO 1 6 8 as ad r s ing the ne ds of
in ivid als with mode at e visual imp irment or bl n nes
NOTE NIS that are not claimed to b ap ropriat e for use by per ons with visual impairments ne d not me t
these req irements, but man facturer are encoura ed to consider them
2 Normati ve r eferences
The folowing document , in w hole or in p rt, ar normatively r fe enc d in this document an ar
in ispensa le for it a pl cation F or dat ed r fe enc s, only the edition cit ed a pl es F or u dat ed
r fe enc s, the lat es edition of the r fe enc d document ( inclu ing any amen ment )a pl es
ISO 1 6 8-1:2 14, Ne dle-b sed injec tio sys tems fr medic al us e — R eq ir ments a d tes t meth ds —
Part 1: Ne dle -b s ed injec tio sys tems
ISO 149 1, Medic al dev ic es — Ap lc ation o ri sk ma a ement to medic al devic es
IEC 6 3 6-1,
1)
Medic al dev ic es — Part 1: Ap lc atio o us abi t y en ine rin to medic al dev ic es
1) Replaces IE 62 6
Trang 83 Terms and definitions
F or the purposes of this document, the fol owing t erms and def initionsa ply
3.1
colour vision deficiency
ina i ity t o dis inguish c rtain shades of colour or in mor seve e cases, se colours at al
3.2
bl n nes
vi s ual ac uit y (3.1 ) les than 3 6
Not e 1t o entry: Having no useful vision
Not e 2t o entry: S e Ta le A.1
3.3
functio al vision
wa in w hich a pe son fu ctions w hen att empting visual tasks, such as r ading, orientation an
mo i ity, activities of daiy lving, visual communication, an visual jo ski s
3.4
functio al visual impairment
significant lmitation of visual ca a i ity that can ot be impro ed b cor e tive lenses, medications, or
surg ery, an r sult in diff iculty ac omplshing visual tasks that ar imp rtant t o the in ivid al
Not e 1t o entry: S e An e A
3.5
mo erate visual impairment
vi s ual ac uit y (3.1 ) betwe n 6 / 18an 6 /6
Not e 1t o entry: S e Ta le A.1
3.6
ne dle-based injection sy stem
NIS
inje tion sy st em int en ed for p r nt eral adminis ration b inje tion of medicinal prod ct using a
ne dle an a multi-dose or single-dose containe
[ SOURCE:ISO 1 6 8-1:2 14, 3 9]
3.7
no -visual me ns
format that uti iz s a sensory channel othe than vision
Not e 1t o entry: Braile is not widely used; therefore,it is not recommen ed as the only tactile format
Not e 2t o entry: Ex mples of non-visual me ns are chan els for e.g tactile, au it ory, olfact ory sensor
3.8
severe visual impairment
vi s ual ac uit y (3.1 ) betwe n 6 /60 an 3 6
Not e 1t o entry: S e Ta le A.1
3 9
user interface
means b w hich the use an the medical devic int eract
[ SOURCE:IEC6 3 6-1:2 1 , 3.2 , modified]
Trang 9visual acuity
sharpnes of vision ex r s ed as a fraction of normal vision
Note 1t o entry: S e An e A
E AMP E T e notation “6 / 12” me ns that a specif ic per on can distinguish an ima e at a distance of 6 m
that a per on with normal vision could distinguish at a distance of 1 m
3.1
visual impairment
sight los that cannot be impro ed b cor e tive lenses
Note 1t o entry: Cor ective lenses can b glas es or contact lenses
4.1 Risk anal ysis requirements
The man factur r’s risk as es ment shal conside risks as ociat ed with the int en ed use of the NIS
for medical purposes, inclu ing use b in ivid als without visual imp irment, as wel as in ivid als
with mode at e visual imp irment an in ivid als with bl n nes
When con ucting the risk as es ment, it is imp rtant t o ac urat ely identify al use groups of the NIS
an any fu ctional charact eris ics of each group that could afe t their use of the NIS Some disease
con itions (e.g dia et es) an some medications(e.g thorazine) can cause visual impairment an some
use groups (e.g elde ly ad lt , w ho might be the p tient or a la car give ) ar mor lkely t o ha e
visual imp irment Some use sof the NIS might ha e colour def iciency, w hich could be as ociat ed with
othe ty es of risks If the e is a p s ibi ty of visual imp irment amongs the NISuse groups, analy sis
of the p t ential efe t of those imp irment on the use s’ int eractionswith the NIS shal be inclu ed in
the risk as es ment
As part of the risk analy sis con uct ed ac ording t o ISO 149 1, the man factur rs shal identify al use
sc narios that could lead t o a hazardous situation or harm an then implement risk control measur s
ne ded t o r d c the risks t o ac epta le levels The adeq acy of the risk control measur s shal be
as es ed in the summative ev luation of the NIS S e 5.2
The as es ment of the risks and benef it as ociat ed with use of the NIS shal conside the fact that
for use s with visual imp irment, the risks might be dife ent from the risks for use s without visual
imp irment The analy sis of risks shal inclu e han lng of the NIS, ac urat e dosing of the spe if ic
drug, an u de s an ing of the information sup led b the man factur r Whie the benef it of the
medicinal prod ct ar the same for b th use groups, the benefit could be gr at er for use s with visual
imp irment d e t o the a i ty t o self-administ er the medicinal prod ct
4.2 General requir ements
4.2.1 NIS desig n
The NIS shal be designed so that a use with mode at e visual imp irment or bl n nes can use it afely
an cor e tly for it int en ed purpose, inclu ing, w he e a plca le, fil ing the NIS with medicinal
prod ct an as embl ng comp nent The r q ir ment in this Clause ma be fulf iled through the use
of an ac es ory (e.g sep rat e devic or mo ie a plcation)
NIS shal clearly in icat e an dis inguish the folowing s at es b visual an non-visual means, i.e
pro iding eq iv lent information in othe sensory format , such as tactie an / r au ible format :
— un sed;
— r ady t o delve ;
Trang 10— del very initiat ed;
— del very complet ed;
— end of useful l fe
NOTE 1 ISO 1 60 -5 uses the t erm “in use”, which inclu es thre of the states list ed a ove: “ re d to deliver,
delivery initiated, an delivery completed”
The NIS design shal me t he fol owing r q ir ment
a) The visual an non-visual information shal be consist ent with each othe Stat e in icat ors shal be
pe sist ent or conf irma le b the use w hie the NIS is in that s at e Whe e a plca le, the NIS shal
alow the use t o det ermine the del ve a le dose b visual an non-visual means
NOT 2 Information presentation can b either per ist ent (constant) or transient (emporary) For
e ample, a contin ous au ible t one would b per istent, where s a single click or “b ep” would b transient
b) The NIS shal alow the use t o as es the a pearanc ofthe medicinal prod ct b visual means, e.g
through as is anc from a sight ed pe son, an w he e p s ible, non-visual means
When the NISr q ir s the use t o pr -set the dose, or the man factur r pr -set the dose, the NIS
shal pro ide an in ication through visual an non-visual means of the dose that has be n set
c) Varia le multi-dose NISs ( y st em designationsA an C, as defined in ISO 1 6 8-1) shal be designed
so that they in icat e, through visual an non-visual means, eithe the amount of the pr -set dose
del ve ed or the amount of the pr -set dose not yet delve ed
d) If the NIS contains b tt eries, it shal be designed t o alow the use t o det ermine the r maining
batt ery charg e b visual an non-visual means
e) The NIS shal ena le the use t o safely identify the location from w hich sharps wi l proje t using
visual an non-visual means Whe e r traction of the ne dle from the inje tion sit e is aut omatic,
in ication of the completion ofne dle r traction shal be pro ided b non-visual means If a tactie
means is used t o identify and verify s atus of the ne dle, it shal be designed in such a wa that he
use of the tactie means it elfwi l not lead t o inc easing risk of ne dle s ick injury
4.2.2 Packag ing desig n
The NIS p cka ing shal be designed so that a use with mode at e visual imp irment or bln nes can
o en it safely an cor e tly, without being harmed or dama ing the NIS
F eatur s pro ided t o faci itat e o ening the p cka ing shal be r adiy a par nt b visual an at leas
one non-visual means
The packa ing shal be designed t o pr vent inadve t ent spi ag e of the packag e cont ent onc the
p cka ing iso ened
If as embly of the NIS is r q ir d, the comp nent shal be p ckag ed in a wa that faci itat es cor e t
identification an as embly
5.1 Verification testing
Tes ing shal be con uct ed t o ve ify that the NIS design was implement ed in ac ordanc with the design
spe ifications, inclu ing those featur s that make the NIS safe an efe tive for use s with visual
imp irment
Trang 11Spe ifications for fu ctions r lat ed t o ac es ibi ty, such as o e ating rang es, ma imum an / r minimum
levels, an dimensional v lues of t ech ical p ramet ers shal be ve if ied F or furthe information, se
An ex C
Whi e la -b sed t es ing an measur ment of the ac es ibi ty-r lat ed use int erfac featur s can form
p rt of a ve if ication pro ram for the prod ct, NIS man factur rs shal be awar that a pro riat e
formative an summative v ldation wi pro ide final evidenc that the int en ed use s can use the NIS
safely an cor e tly
5.2 Summati ve evaluation (val dation testing )
5.2.1 General
Whe e the int ended use groups ar identified as inclu ing peo le with visual imp irment, such use s
shal be inclu ed in summative ev luation con uct ed on the NISan it p cka ing an la el ing
The summative ev luation of the NIS shal be con uct ed ac ording t o IEC 6 3 6-1 an inclu e the use
p pulations an cont ext of use
5.2.2 Use pop lations
Summative ev luation of a NIS that folow s this p rt of ISO 1 6 8 shal inclu e the int en ed use s
F or the purp ses of r c uiting peo le with visual impairment t o p rticipat e in summative ev luation of
a NIS, an charact erizing their level of impairment, measuring fu ctional vision might be simple an
mor a pro riat e and useful than measuring visual acuity Stan ardiz d ins rument ar a ai a le for
this purp se The man factur r shal pro ide a rationale for their choic t o measur eithe fu ctional
vision or visual acuity, an the spe if ic measur ment ins rument ele t ed S e Annex A
5.2.3 C ntex t of use
The cont ext ofuse for the NIS shal be conside ed in the risk as es ment Al aspe t of the cont ext of
use that could afe t use s’ a i ity t o use the NIS safely an cor e tly shal be incorp rat ed int o the
summative ev luation
Aspe t of the cont ext of use that ar p rticularly important t o use s with visual impairment inclu e
any environmental con itions that could afe t use s’ pe c ption of information F or ex mple, l ghting
con itions (e.g low lght or glar ) can afe t the a i ity of use s with mode at e visual imp irment
t o pe c ive visual information pro ided b the use int erfac Ambient noise levels an acous ic
charact eris ics of the environment (e.g r ve be ation) can afe t the a i ity of use s t o pe c ive
au it ory information pro ided b the use int erfac Cold t empe atur s can afe t use s’ a i ty t o
pe c ive tacti e information
Anothe aspe t ofthe cont ext of usethat is p rticular t o use s with visual imp irment is use of as is ive
t ech olo ies Some use s wi l use glas es or ma nifying t ech olo ies t o pe c ive visual information
Some use s wi l use sou d ampl fie s t o pe c ive au it ory information
6 Test r eport
S e ISO 1 6 8-1 an IEC 6 3 6-1
Trang 127 Information suppl ed by the manufactur er
7.1.1 Overview
Al visual information r q ir d for safe an efe tive use of the NIS shal be pe c ptible an
compr hensible t o use s with mode at e visual imp irment Use s with bln nes shal be a le t o
ac es the same information through non-visual means The visual an non-visual information shal be
consist ent with each othe
7.1.2 Tacti e information
Information can be commu icat ed through tacti e means
Tactie information can be pro ided in format such as raised charact ers, vibration, dis inctly sha ed
controls, brai e, an othe featur s The efe t of deg ene ative diseases an neuro athy in the p tient
p pulation of the int en ed NIS shal be conside ed in the design of any tacti e commu ication methods
NOTE S e ISO/TR 2 411:2 0 , 8.2.2.1 for guidance on suita le tactile markings ISO/TR 2 411:2 0 ,
9.2.3.2,9.2.3.3 an 9.2.4 provide guidance on the spatial an t emporal resolution of the tactile sense, as wel as
the thermal sense ISO 245 3 provides req irements for improving the ac es ibility of consumer prod cts used
by per ons with visual impairment, an in cases where visual information is not the primary sense used for
ac omplishing the task
7.1.3 Auditory infor mation
Information can be commu icat ed b au it ory means
A udit ory information can be pro ided in format such as synthesiz d or r corded spe ch, melodies,
clcking, be ping, or buz ing
NOTE S e ISO/TR 2 411:2 0 , 8.2.2.2 for guidance on efective design of au itory fe db ck ISO 245 0
provides guidance for improving the usa ility an ac es ibility of au itory signals used in consumer prod cts,
there y facilitating use by al pe ple, inclu ing pe ple with visual impairments an older pe ple with a
e-related he ring impairments ISO 245 1 specif ies methods for determining an ap ropriate sou d level rang e for
au it ory signals, so that al prod ct user , inclu ing pe ple with a e-related he ring los , can he r them properly
a ainst interfering sou ds
7.1.4 Infor mation provided in electronic for mat
Information can be commu icat ed through ele tronic means
Ele tronic information can be pro ided in format such as codes or signals int en ed t o int eract with
han -held devic s, dedicat ed r ade s, or as is ive t ech olo ies
NOTE One e ample of an electronic marking is a QR (q ick response) code, which is a form or optical y
machine-re da le ima e that convey s information such as t ext or a website ad res ISO/IE 1 0 4 def ines the
req irements for the symb lo y, k own as QR Code 2 0
7.2 Mar king
7.2.1 Mar king o the NIS
The NIS markings shal ena le the use t o ac es the same information r q ir d in ISO 1 60 -1:2 14,
1 2.2, b non-visual means
Trang 13Flashing, bl n ing, sc ol ng, or flckering display s can be difficult for use s with mode at e visual
imp irment t o r ad Dis racting or un e es ary information should not be pr sent ed t o the use
NOTE 1 T e fol owing International Stan ards provide useful guidance:
— ISO/TR 2 411:2 0 , 8.5, 8.6 an 8.8 provide usefulguidance on improving le ibility an comprehension of
te t an grap ic markings
— ISO 245 2 provides a method of calculating a e-related luminance contrast hat can b used for as es ing
an designing signs an visual display s so that they are cle rly visible to older pe ple
NOTE 2 T e risk as es ment could in icate that the NIS markings should ena le the user t o distinguish it from
similar NIS in the same en ironment
7.2.2 Mar king on the unit packag ing
The markings on the packa ing shal ena le the use t o ac es the same information r q ir d in
ISO 1 60 -1:2 14, 1 2.3 b visual an at leas one non-visual means
Markings shal be r adi y locata le b non-visual means an comp tible with as is ive r ading
t ech olo ies
NOTE Tech olo ies that might b used to re d the packa ing markings inclu e as istive re ding tech olo ies
that utilize machine-re da le code, webbrowser lin s t o websit es, telep one, an / r ma nif ication
7.3 Instructions for use
Al information in the ins ructions for use shal be a aia le t o use s with visual imp irment
This information shal be pro ided through visual means usa le b pe sons with mode at e visual
imp irment and through at leas onenon-visual means
The ins ructions for use shal inclu e information in clear languag e t o faci tat e use of the NIS b
pe sons with visual impairment, inclu ing r fe enc t o al non-visual information pro ided b an
markings on the NIS F or ex mple, w he e a plca le, the folowing information shal ex lain how t o,
safely an cor e tly,
— r mo e the p rt of the NIS from the p cka ing,
— identify the part of the NIS an ne es ary consuma le comp nent an as emble them cor e tly,
— det ermine how much medicinal prod ct is in the NIS,
— f il the devic with the medicinal prod ct,
— combine sep rat e component of medicinal prod ct ,
— cond ct priming st eps or othe dose delve y pr paration,
— set the dosag e in the NIS,
— del ve a complet e dose with the NIS,
— det ermine how much medicinal prod ct was delve ed b the NIS,
— r mo e an r ins al r plac a le comp nent ,
— disas emble the NIS,
— disp se of the NIS or consuma le comp nent ,
— det ect the cor e t orientation of the b tt ery or batt eries, an
— pe form troublesho ting